Pharma companies may lose licence if drugs fail tests

The health ministry is considering strict actions, including immediate license suspensions, for drugmakers producing substandard drugs. This proposal follows concerns about quality control and aims to safeguard public health. Pharma lobby groups have raised objections, citing technical issues and questioning the standards of government testing laboratories, while advocating for a stronger recall mechanism.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/GeNpgHz
via IFTTT